Sort
16,300 grants matching “fatty liver disease”
Therapeutic Mitochondrial Uncouplers
$542,417Webster L Santos · Virginia Polytechnic Inst And St Univ · R01 · FY2023 · DK
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
$542,407Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Impact of GLP-1 on Hepatic Fat and Energy Utilization in Obese Girls with Polycystic Ovarian Syndrome
$542,337Melanie G Cree · University Of Colorado Denver · R01 · FY2022 · DK
Relevance of fatty acid handling in the adaptive response to mitochondrial dysfunction
$542,156Erin Seifert · Thomas Jefferson University · R01 · FY2024 · DK
Notch Signaling in the Adult Lymphatic Vasculature
$542,024Carrie J. Shawber · Columbia University Health Sciences · R01 · FY2025 · HL
Red Blood Cell Endothelial Nitric Oxide Attenuates Insulin Resistance
$541,832Francis Kim · University Of Washington · R01 · FY2018 · HL
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and
$541,769Adrian Friedrich Gombart · Oregon State University · R01 · FY2017 · AT
Core--Imaging
$541,547Melvin E Clouse · Beth Israel Deaconess Medical Center · P50 · FY2008 · HL
Insulin Signaling, Lipoproteins and Atherosclerosis
$541,497Alan Richard Tall · Columbia University Health Sciences · P01 · FY2011 · HL
Novel Pathways of Cellular Cholesterol Efflux
$541,489Alan Richard Tall · Columbia University Health Sciences · P01 · FY2008 · HL
Targeting Scap to Lower ApoB-Containing Lipoproteins (ApoBCL) Production
$541,200Arun Radhakrishnan · Ut Southwestern Medical Center · P01 · FY2022 · HL
Targeting Scap to Lower ApoB-Containing Lipoproteins (ApoBCL) Production
$541,200Arun Radhakrishnan · Ut Southwestern Medical Center · P01 · FY2023 · HL
Perilipin 5 in the Regulation of Adipose Tissue Function
$541,200Perry E Bickel · Ut Southwestern Medical Center · R01 · FY2025 · DK
Perilipin 5 in the Regulation of Adipose Tissue Function
$541,200Perry E Bickel · Ut Southwestern Medical Center · R01 · FY2023 · DK
Identification of senescent cell types
$541,140Laura Jane Niedernhofer · University Of Minnesota · P01 · FY2024 · AI
Molecular mechanisms underlying the genetic association between PPP1R3B and hepatic steatosis
$541,108Daniel James Rader · University Of Pennsylvania · R01 · FY2021 · DK
Comprehensive quantitative ultrafast 3D liver MRI
$541,026Vikas Gulani · Case Western Reserve University · R01 · FY2016 · DK
Rho-kinase signaling in energy balance
$540,814Young-Bum Kim · Beth Israel Deaconess Medical Center · R01 · FY2024 · DK
Neurodevelopmental and neurodegenerative effects of environmental determinants: altering neural cellular populations impacting homeostatic functions and inflammatory response.
$540,813Nicholas Francis Fitz · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AG
Phosphatidylinositol Metabolism and Trafficking in Atherosclerosis and Inflammation
$540,777Kailash Gulshan · Cleveland State University · R01 · FY2025 · HL
Phosphatidylinositol Metabolism and Trafficking in Atherosclerosis and Inflammation
$540,777Kailash Gulshan · Cleveland State University · R01 · FY2024 · HL
Role of liver fat and fibrosis in human CVD risk phenotypes.
$540,686Rohit Loomba · University Of California, San Diego · P01 · FY2024 · HL
Omega 3 Fatty Acids, Acute Neuroprotection Via Mitochondria
$540,539Chuchun Liz Chang · Columbia University Health Sciences · R01 · FY2024 · NS
The role of PKM2 in dietary lipid absorption and fructose-induced obesity
$540,407Marcus Dasilva Goncalves · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · DK
QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload
$540,298Yi Wang · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · DK